Prevention of adverse effects of BCG immunotherapy in bladder cancer

South Med J. 2008 Jan;101(1):17-8. doi: 10.1097/SMJ.0b013e31815d4102.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Intravesical
  • BCG Vaccine / administration & dosage
  • BCG Vaccine / adverse effects*
  • BCG Vaccine / therapeutic use
  • Humans
  • Immunotherapy
  • Nucleic Acid Synthesis Inhibitors / therapeutic use
  • Ofloxacin / therapeutic use
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • BCG Vaccine
  • Nucleic Acid Synthesis Inhibitors
  • Ofloxacin